Mohammad Abu Hilal
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis 93
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research 134
- Surgery top 0.5%
- Cholangiocarcinoma and Gallbladder Cancer Studies 61
- Pancreatitis Pathology and Treatment 47
- Pulmonary and Respiratory Medicine top 0.5%
- Gallbladder and Bile Duct Disorders 62
- Gastric Cancer Management and Outcomes 28
- Renal cell carcinoma treatment 21
- Gastroenterology top 2%
-
- Liver Disease Diagnosis and Treatment 16
- Co-authors
- Neil W. PearceJohn PrimroseMarc G. BesselinkFederica CiprianiFrancesco Di FabioLuca AldrighettiBjørn EdwinMark McPhail
- Cited by
- HepatologyOncologySurgery
- Journals
- The Lancet (1 paper)Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (3 papers)
- Partner nations
- United KingdomItalyNetherlands
In The Last Decade
Mohammad Abu Hilal
231 papers receiving 5.7k citations
Peers
Comparison fields: 5 of 123
- Hepatology 2.6k
- Oncology 3.5k
- Surgery 3.4k
- Pulmonary and Respiratory Medicine 2.3k
- Gastroenterology 224
Countries citing papers authored by Mohammad Abu Hilal
This map shows the geographic impact of Mohammad Abu Hilal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Abu Hilal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Abu Hilal more than expected).
Fields of papers citing papers by Mohammad Abu Hilal
This network shows the impact of papers produced by Mohammad Abu Hilal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Abu Hilal. The network helps show where Mohammad Abu Hilal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mohammad Abu Hilal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 10 | |
| 4 | 2023 | 17 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 9 | |
| 8 | 2022 | 13 | |
| 9 | 2021 | 6 | |
| 10 | 2021 | 8 | |
| 11 | 2019 | 46 | |
| 12 | 2019 | 9 | |
| 13 | 2019 | 33 | |
| 14 | 2019 | 53 | |
| 15 | 2018 | 119 | |
| 16 | 2015 | 16 | |
| 17 | Overcoming obstacles to establish a multidisciplinary team approach to hepatobiliary diseases: a working model in a Caribbean setting | 2014 | 0 |
| 18 | 2012 | 19 | |
| 19 | 2011 | 28 | |
| 20 | 2006 | 6 |
About Mohammad Abu Hilal
Mohammad Abu Hilal is a scholar working on Hepatology, Oncology and Surgery, having authored 247 papers that have together received 5.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (134 papers), Hepatocellular Carcinoma Treatment and Prognosis (93 papers), Gallbladder and Bile Duct Disorders (62 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (61 papers), Pancreatitis Pathology and Treatment (47 papers), Gastric Cancer Management and Outcomes (28 papers), Renal cell carcinoma treatment (21 papers) and Liver Disease Diagnosis and Treatment (16 papers). The work is most often cited by research in Hepatology (2.6k citations), Oncology (3.5k citations) and Surgery (3.4k citations). Mohammad Abu Hilal has collaborated with scholars based in United Kingdom, Italy and Netherlands. Frequent co-authors include Neil W. Pearce, John Primrose, Marc G. Besselink, Federica Cipriani, Francesco Di Fabio, Luca Aldrighetti, Bjørn Edwin, Mark McPhail, Roberto Troisi and Thomas Armstrong. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.